http://jcps.bjmu.edu.cn

• 研究论文 • 上一篇    下一篇

血小板活化因子受体拮抗剂海风藤酮的特性:对血小扳活化因子体内、体外的特异性抑制作用

沈忆征, 李长龄, 王银叶, 郭小东, 韩桂秋   

  1. 北京医科大学药学院生化药理组
  • 收稿日期:1992-09-22 修回日期:1993-10-15 出版日期:1994-06-15 发布日期:1994-06-15

Characterization of a Platelet-Activating Factor Receptor Antagonist, Kadsurenone:Specific Inhibition of Platelet-activating Factor in vitro and in vivo

Yi-Zheng Shen, Chang-Ling Li, Yin-Yie Wang, Xiao-Dong Guo, Gue-QiuHan   

  1. Department of Biochemical Pharmacology, School of Pharmaceutical Sciences, Beijing Medical University, Beijing, 100083
  • Received:1992-09-22 Revised:1993-10-15 Online:1994-06-15 Published:1994-06-15

摘要: 海风藤酮是从中药海风藤(Piper futokadsura)中提取的一种木脂素。本文运用放射配基受体分析及血小板聚集观察海风藤酮的作用, 发现海风藤酮特异性地抑制血小板活化因子(PAF)与洗涤的兔血小板结合, ki2×10-12 mol/L, 体外实验显示特异性地抑制PAF引起的血小板聚集, IC502.6 μmol/L, 而对APPAA引起的血小板聚集无效。半体内实验表明, 0.1 mg/kg海风藤酮抑制PAF引起血小板聚集的作用, 可维持2小时。静脉(71 mg/kg, 14.2 mg/kg)及口服(80 g/kg; 120 mg/kg)海风藤酮抑制大鼠体内血小板血栓形成, 其抑制率分别为25.4%, 38.2%, 21.4%34.6%以上结果表明, 海风藤酮是一血小板活化因子的特异性受体拮抗剂。

关键词: 血小板活化因子(PAF), 海风藤酮, 受体, 血小板, 血栓形成

Abstract: Kadsurenone (Kad) is a lignan isolated from the Chinese herbal plant Heifenteng (Piper futokadsura). In the present paper the effects of Kad on PAF receptor using radioligand binding assay, as well as on rabbit platelet aggregation are reported. The experimental results indicated that Ked is a potent and specific PAF antagonist. The Ki value of Kad binding PAF receptor of washed rabbit platelets was found to be 2×10-12 mol/L. Experiment in vitro showed that the rabbit platelet aggregation induced by PM was inhibited by Kad (IC50 = 2.6 μmol/L). However, no inhibitory effecton the aggregation induced by arachidonic acid and ADP was observed. Kad (0.1 mg/kg, iv)completely inhibited PAF-induced platelet aggregation in rabbits and the effect lasted for 2 hr. The formation of platelet thrombus in rats was inhibited by iv Kad (7.1 mg/kg; 14.2 mg/kg) or po (80 mg/kg, 120 mg/kg).The inhibitory rate of Kad was 25.4%, 38.2%, 21.4% and 34.6% respectively. It issuggested that the PAF is an important factor in thrombosis and Kad is a specific PAF receptor an-tagonist .

Key words: Platelet Activating Factor (PAF), Kadsurenone (Kd), Receptor, Platelet, Thrombosis

Supporting: